학술논문
Single Dose of Ivermectin is not Useful in Patients with Hematological Disorders and COVID-19 Illness: A Phase II B Open Labelled Randomized Controlled Trial.
Document Type
Article
Author
Source
Indian Journal of Hematology & Blood Transfusion; Oct2022, Vol. 38 Issue 4, p615-622, 8p
Subject
Language
ISSN
09714502
Abstract
Copyright of Indian Journal of Hematology & Blood Transfusion is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)